logo
The Friendship Bench: Bringing talk therapy into underserved communities

The Friendship Bench: Bringing talk therapy into underserved communities

Yahoo09-02-2025

Dr. Dixon Chibanda remembers like yesterday the moment in 2005 that changed his life. "During my formative years working as a psychiatrist, I lost a patient of mine to suicide. Erica was her name. She had hanged herself from a mango tree in the family garden."
Erica was just 25 years old.
Chibanda, a psychiatrist based in Harare, Zimbabwe, says her family knew she needed help. "They lived some 200 miles away from where I worked," he said. "And they just didn't have the equivalent of US$15 to get onto a bus to come to the hospital."
At the time, there were only 10 psychiatrists serving 13 million people in Zimbabwe. So, Chibanda came up with an idea involving grandmothers: "These grandmas were actually, you know, the custodians of the local culture and the wisdom, and they were rooted in their communities. And I was like, what if we could train them to be the first port of call for anyone needing to talk in a community?"
So, in 2006, Chibanda introduced the "Friendship Bench," a talk therapy program that brings mental healthcare directly into underserved communities. The program is free, and the grandmothers were happy to donate their time.
He chronicled this journey in a new book: "The Friendship Bench: How Fourteen Grandmothers Inspired a Mental Health Revolution" (New World Library).
"When I first started this, in fact we called it the Mental Health Bench," he said. "Interestingly, nobody came to the Mental Health Bench, because of the stigma, until the grandmas said, 'You know, why don't you turn it into a Friendship Bench?'"
During that first year, 14 volunteer grandmothers shared a Friendship Bench with several hundred visitors in that one suburb. Chibanda says the program has since expanded beyond grandmothers to include over 3,000 older listeners who last year saw more than 300,000 people all over Zimbabwe.
He said, "There are a lot of people out there who are struggling to just connect with another human being. And this gives them that opportunity, to be able to sit down with someone who is empathic."
Globally, just under 300 million people are struggling with depression, according to the World Health Organization. Only about one-third of them receive any treatment. And at a time when we're facing an epidemic of loneliness and isolation affecting 1 in 5 American adults (according to a 2024 Gallup poll), the Friendship Bench is hitting the road, expanding to vulnerable communities in 9 countries and counting, including the United States.
At the Washington Seniors Wellness Center, in our nation's capital, the program is being piloted by the nonprofit organization HelpAge USA, which focuses on the inclusion of older people.
Seventy-four-year-old Arnette Ibitayo says she was struggling with the deaths of her son and brother. "My son's was sudden; he had a heart attack at 44," she said. "And then my brother had COVID."
She turned to the Friendship Bench. "So I'm, you know, feeling down, depressed," she said. "I think I need to talk to somebody, because I felt like isolating and staying home. And it was very comforting to get it out. And I wasn't judged, and I was able to speak freely, and the person gave me some helpful advice."
That person was Theresa Kelly, a retired schoolteacher, who listened to Ibitayo's story. "We don't solve problems for them," Kelly said. "Sometimes you don't realize that you can be your own problem solver. And when they finish, we want them to leave empowered."
A screening process refers more serious cases to professionals. For almost 20 years now, Dr. Chibanda has been using his medical training to help analyze and improve the program. "The Friendship Bench is actually rooted in a lot of research," he said. "These grandmas were a lot more effective than trained mental health professionals at alleviating symptoms of both depression and generalized anxiety disorders."
Arnette Ibitayo said she felt better after just one session with Kelly: "I was more at ease. It worked. It was working."
"You feel a little less depressed now?" I asked.
"Yes, uh-huh. There's hope that things are going to be better."
So, what's the special sauce when it comes to grandparents? According to Chibanda, it is "the natural abilities that come with having a long-lived life on the planet. They've seen a lot. They've experienced a lot. They have, you know, the battle scars of life, which they bring to the bench. All we're doing as Friendship Bench is helping them to use those stories, those experiences, to help others."
And the bench is giving them something back. Theresa Kelly said, "I love helping people, empowering people. It makes me feel good. Makes me feel that [I have] still another purpose, that after retirement there's still something, you know, that I can do that can help others, that it's not over."
For more info:
friendshipbench.orgDixon Chibanda, Centre for Global Mental HealthAfrican Mental Health Research Initiative (AMARI)Friendship Bench DC (HelpAge USA)Washington Seniors Wellness Center, Washington, D.C.Documentary: "The Friendship Bench" (SeaLion Films)"The Friendship Bench: How Fourteen Grandmothers Inspired a Mental Health Revolution" by Dixon Chibanda, MD (New World Library), in Trade Paperback and eBook formats, available April 22 via Amazon, Barnes & Noble and Bookshop.org
Story produced by Robbyn McFadden. Editor: Joseph Frandino.
If you or someone you know is in emotional distress or a suicidal crisis, you can reach the 988 Suicide & Crisis Lifeline by calling or texting 988. You can also chat with the 988 Suicide & Crisis Lifeline here.
For more information about mental health care resources and support, The National Alliance on Mental Illness (NAMI) HelpLine can be reached Monday through Friday, 10 a.m.–10 p.m. ET, at 1-800-950-NAMI (6264) or email info@nami.org.
See also:
Chip Reid on addressing the long-term mental health of U.S. service members ("Sunday Morning")Addressing the pandemic's mental health fallout ("Sunday Morning")Recognizing the signs of postpartum depression ("Sunday Morning")SAINT: Hope for new treatment of depression ("Sunday Morning")Melissa & Doug co-founder opens up about her secret struggle ("Sunday Morning")Reaching out: How caring letters help in suicide prevention ("Sunday Morning")
Extended interview: Cynthia Erivo
The Friendship Bench: Bringing talk therapy into underserved communities
Weaving a fascination for lace

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

In letter, more than 300 scientists rebuke Trump research cuts, NIH director
In letter, more than 300 scientists rebuke Trump research cuts, NIH director

Yahoo

timean hour ago

  • Yahoo

In letter, more than 300 scientists rebuke Trump research cuts, NIH director

June 9 (UPI) -- Hundreds of scientists via the National Institute of Health signed a published letter in protest to NIH leadership and recent cuts by the Trump administration. "We are compelled to speak up when our leadership prioritizes political moment over human safety and faithful stewardship of public resources," more than 300 scientists wrote Monday to NIH Director Jay Bhattacharya in a so-called "Bethesda Declaration" published by Stand Up For Science in rebuke to Trump administration research funding cuts and staff layoffs. They added in the letter to U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and members of Congress overseeing NIH that they "dissent" to Trump's policies that "undermine" the NIH mission, "waste" public resources and harm "the health of Americans and people across the globe." In the open letter, they said the current endeavor to "Make America Healthy Again" referred to "some undefined time in the past." "Keeping NIH at the forefront of biomedical research requires our stalwart commitment to continuous improvement," the letter's writers said, adding that the life-and-death nature of NIH work "demands that changes be thoughtful and vetted." According to the letter, the Trump administration terminated at least 2,100 NIH research grants since January, totaling around $9.5 billion and contracts representing some $2.6 billion in new research. "We urge you as NIH Director to restore grants delayed or terminated for political reasons so that life-saving science can continue," the letter added in part. "This undercuts long-standing NIH policies designed to maximize return on investment by working with grantees to address concerns and complete studies," it said. It further accused the White House of creating a "culture of fear and suppression" among NIH researchers. Bhattacharya, a Stanford University professor and health researcher, called the agency the "crown jewel of American biomedical sciences" and said he had the "utmost respect" for its scientists and mission during his confirmation hearing in March. On Tuesday, Bhattacharya is scheduled to testify before the Senate's Appropriations Committee on Trump's 2026 NIH budget proposal which seeks to cut roughly 40% of NIH's $48 billion budget. "This spending slowdown reflects a failure of your legal duty to use congressionally-appropriated funds for critical NIH research," the scientists penned to Bhattacharya. The letter goes on to characterize it as "dissent" from Trump administration policy, quoting Bhattacharya during his confirmation as saying "dissent is the very essence of science." "Standing up in this way is a risk, but I am much more worried about the risks of not speaking up," says Jenna Norton, a program officer at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases. "If we don't speak up, we allow continued harm to research participants and public health in America and across the globe," Norton said in a statement, adding that if others don't speak up, "we allow our government to curtail free speech, a fundamental American value."

In letter, more than 300 scientists rebuke Trump research cuts, NIH director
In letter, more than 300 scientists rebuke Trump research cuts, NIH director

UPI

timean hour ago

  • UPI

In letter, more than 300 scientists rebuke Trump research cuts, NIH director

June 9 (UPI) -- Hundreds of scientists via the National Institute of Health signed a published letter in protest to NIH leadership and recent cuts by the Trump administration. "We are compelled to speak up when our leadership prioritizes political moment over human safety and faithful stewardship of public resources," more than 300 scientists wrote Monday to NIH Director Jay Bhattacharya in a so-called "Bethesda Declaration" published by Stand Up For Science in rebuke to Trump administration research funding cuts and staff layoffs. They added in the letter to U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and members of Congress overseeing NIH that they "dissent" to Trump's policies that "undermine" the NIH mission, "waste" public resources and harm "the health of Americans and people across the globe." In the open letter, they said the current endeavor to "Make America Healthy Again" referred to "some undefined time in the past." "Keeping NIH at the forefront of biomedical research requires our stalwart commitment to continuous improvement," the letter's writers said, adding that the life-and-death nature of NIH work "demands that changes be thoughtful and vetted." According to the letter, the Trump administration terminated at least 2,100 NIH research grants since January, totaling around $9.5 billion and contracts representing some $2.6 billion in new research. "We urge you as NIH Director to restore grants delayed or terminated for political reasons so that life-saving science can continue," the letter added in part. "This undercuts long-standing NIH policies designed to maximize return on investment by working with grantees to address concerns and complete studies," it said. It further accused the White House of creating a "culture of fear and suppression" among NIH researchers. Bhattacharya, a Stanford University professor and health researcher, called the agency the "crown jewel of American biomedical sciences" and said he had the "utmost respect" for its scientists and mission during his confirmation hearing in March. On Tuesday, Bhattacharya is scheduled to testify before the Senate's Appropriations Committee on Trump's 2026 NIH budget proposal which seeks to cut roughly 40% of NIH's $48 billion budget. "This spending slowdown reflects a failure of your legal duty to use congressionally-appropriated funds for critical NIH research," the scientists penned to Bhattacharya. The letter goes on to characterize it as "dissent" from Trump administration policy, quoting Bhattacharya during his confirmation as saying "dissent is the very essence of science." "Standing up in this way is a risk, but I am much more worried about the risks of not speaking up," says Jenna Norton, a program officer at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases. "If we don't speak up, we allow continued harm to research participants and public health in America and across the globe," Norton said in a statement, adding that if others don't speak up, "we allow our government to curtail free speech, a fundamental American value."

3 Healthcare Stocks Skating on Thin Ice
3 Healthcare Stocks Skating on Thin Ice

Yahoo

timean hour ago

  • Yahoo

3 Healthcare Stocks Skating on Thin Ice

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 12.3%. This performance was noticeably worse than the S&P 500's 1.9% fall. Investors should tread carefully as the influx of venture capital has also ushered in a new wave of competition. Taking that into account, here are three healthcare stocks we're swiping left on. Market Cap: $48.91 billion With a history dating back to 1897 and a presence in virtually every hospital around the globe, Becton Dickinson (NYSE:BDX) develops and manufactures medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions and professionals worldwide. Why Do We Think Twice About BDX? Annual sales growth of 4.1% over the last five years lagged behind its healthcare peers as its large revenue base made it difficult to generate incremental demand 10.5 percentage point decline in its free cash flow margin over the last five years reflects the company's increased investments to defend its market position Below-average returns on capital indicate management struggled to find compelling investment opportunities BD is trading at $170.95 per share, or 11.4x forward P/E. If you're considering BDX for your portfolio, see our FREE research report to learn more. Market Cap: $8.28 billion With a unique business model combining end-of-life care and household services, Chemed (NYSE:CHE) operates two distinct businesses: VITAS, which provides hospice care for terminally ill patients, and Roto-Rooter, which offers plumbing and water restoration services. Why Does CHE Fall Short? 4.6% annual revenue growth over the last five years was slower than its healthcare peers Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 8.9 percentage points Waning returns on capital imply its previous profit engines are losing steam At $568.39 per share, Chemed trades at 22x forward P/E. Read our free research report to see why you should think twice about including CHE in your portfolio, it's free. Market Cap: $10.73 billion Formerly known as PerkinElmer until its rebranding in 2023, Revvity (NYSE:RVTY) provides health science technologies and services that support the complete workflow from discovery to development and diagnosis to cure. Why Is RVTY Risky? Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth Day-to-day expenses have swelled relative to revenue over the last five years as its adjusted operating margin fell by 8.8 percentage points Eroding returns on capital suggest its historical profit centers are aging Revvity's stock price of $91.03 implies a valuation ratio of 17.6x forward P/E. Check out our free in-depth research report to learn more about why RVTY doesn't pass our bar. Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store